Taken together, these results suggest that there is an association between the expression of proinflammatory mediators such as TNF-α, IL-1β, and 5-LOX and the severity of inflammation among patients with JT, OA, and RA [19]. This evidence concerns the gene ALOX5 and rheumatoid arthritis.